- Home
- DPRO vs ORMP Comparison
DPRO vs ORMP Comparison
Compare DPRO & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DPRO | ORMP |
|---|---|---|
| Founded | 1998 | 2002 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 188.8M | 165.3M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | DPRO | ORMP |
|---|---|---|
| Price | $4.31 | $4.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 516.0K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 0.91 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | $158.69 | N/A |
| Revenue Next Year | $131.85 | N/A |
| P/E Ratio | ★ N/A | $4.42 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $3.85 | $1.98 |
| 52 Week High | $14.37 | $5.19 |
Technical Indicators
Market Signals| Indicator | DPRO | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 35.89 | 46.05 |
| Support Level | N/A | $3.87 |
| Resistance Level | $5.69 | $4.22 |
| Average True Range (ATR) | 0.27 | 0.19 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 19.75 | 14.75 |
Price Performance
Historical ComparisonAbout DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The two segments are Drones, and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.